Werewolf Therapeutics, Inc. - Common Stock (HOWL)

CUSIP: 95075A107

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
47,916,629
Total 13F shares
23,882,934
Share change
-162,205
Total reported value
$51,107,776
Price per share
$2.14
Number of holders
34
Value change
-$364,729
Number of buys
12
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 95075A107?
CUSIP 95075A107 identifies HOWL - Werewolf Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q3 2023

As of 30 Sep 2023, Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,882,934 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM Health Sciences, LP, MPM BIOIMPACT LLC, Rubric Capital Management LP, BANK OF AMERICA CORP /DE/, ADAGE CAPITAL PARTNERS GP, L.L.C., SPHERA FUNDS MANAGEMENT LTD., DC Funds, LP, and VANGUARD GROUP INC. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.